The AWAK PD is a portable peritoneal dialysis device that allows dialysis patients to decide when and where they get their therapy delivered. It employs AWAK’s sorbent technology, which regenerates and reconstitutes used dialysis fluid into fresh fluid, and uses only two litres of PD fluid to deliver the daily therapy. This eliminates the need for a continuous water supply and large volumes of PD fluid used in current methods.

The ClearCell^® FX1 System developed by Singapore-based startup Biolidics is a f fully automated device for cell retrieval in liquid biopsies. From a small blood sample, it can isolate and enrich varied populations of circulating tumour cells. Once the sample has passed through the ClearCell^® FX1 System the enriched output is then ready for downstream analysis.

CroíValve has developed a safe, effective, easy to use, percutaneous solution for treating all patients with severe Tricuspid Regurgitation. It can be delivered through a vein and into the heart, restoring the function of the tricuspid valve. The device seals the central gap between the native valve leaflets preventing regurgitation.

Sutrue has created automated medical stitching devices that are faster, more accurate and less traumatic to tissue than traditional techniques. The devices also protect the operator and ancillary staff from the sharp needle which in traditional suturing leads to needlestick injuries.